Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.
Key Metrics
as of Sep 2026
Market Cap 365 Cr
P/E 33.70
Div Yield 0.37 %
Book Value โน203.00
52w High โน454.00
52w Low โน210.00
Face Value โน10.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
47.90
60.65
46.91
47.17
43.04
29.61
45.14
44.74
43.05
47.32
46.50
43.54
41.94
Expenses
43.57
55.22
42.53
42.01
38.43
31.22
38.43
39.43
39.60
41.57
41.60
38.89
34.99
Operating Profit
4.33
5.43
4.38
5.16
4.61
-1.61
6.71
5.31
3.45
5.75
4.90
4.65
6.95
OPM %
9.04
8.95
9.34
10.94
10.71
-5.44
14.86
11.87
8.01
12.15
10.54
10.68
16.57
Other Income
0.86
1.74
0.53
0.37
0.47
5.23
0.14
0.29
0.59
0.57
0.83
0.55
0.38
Depreciation
1.79
1.73
1.83
1.86
1.80
0.48
2.21
2.61
1.77
1.77
1.80
1.82
1.69
Interest
0.83
0.38
0.97
0.99
1.15
0.65
0.76
1.04
0.71
1.89
0.65
0.91
0.96
Profit before tax
2.57
5.06
2.11
2.68
2.13
2.49
3.88
1.95
1.56
2.66
3.28
2.47
4.68
Tax %
28.40
12.06
22.27
21.27
24.88
25.30
24.74
53.85
48.72
22.93
38.11
39.68
15.81
Net Profit
1.85
4.45
1.64
2.12
1.60
1.87
2.92
0.91
0.80
2.04
2.03
1.47
3.95
EPS in Rs
1.56
2.85
1.61
1.97
1.59
1.90
2.73
1.15
1.06
1.68
1.90
1.19
3.30
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales
198.00 163.00 179.00 141.00 115.00 113.00 125.00 123.00
Expenses
178.00 148.00 156.00 117.00 91.00 93.00 106.00 105.00
Operating Profit
20.00 14.00 24.00 24.00 24.00 20.00 20.00 17.00
OPM %
10.00 9.00 13.00 17.00 21.00 17.00 16.00 14.00
Other Income
3.00 6.00 2.00 2.00 2.00 1.00 2.00 4.00
Interest
4.00 4.00 6.00 3.00 2.00 2.00 1.00 1.00
Depreciation
7.00 7.00 7.00 6.00 6.00 3.00 2.00 2.00
Profit before tax
12.00 10.00 13.00 17.00 18.00 16.00 18.00 18.00
Tax %
18.00 34.00 27.00 14.00 18.00 26.00 26.00 31.00
Net Profit
10.00 7.00 9.00 15.00 15.00 12.00 13.00 12.00
EPS in Rs
7.11 5.59 8.60 11.73 12.20 9.93 10.88 10.28
Dividend Payout %
14.00 18.00 12.00 9.00 8.00 10.00 5.00 10.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Equity Capital
14.00 13.00 13.00 13.00 12.00 12.00 12.00 12.00
Reserves
262.00 200.00 194.00 181.00 134.00 121.00 109.00 75.00
Borrowings
48.00 34.00 31.00 26.00 26.00 19.00 11.00 12.00
Other Liabilities
49.00 50.00 56.00 59.00 53.00 42.00 49.00 38.00
Total Liabilities
372.00 297.00 295.00 279.00 226.00 194.00 181.00 137.00
Fixed Assets
85.00 87.00 92.00 93.00 92.00 90.00 34.00 24.00
CWIP
0.00 0.00 0.00 0.00 0.00 0.00 40.00 15.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
287.00 210.00 203.00 186.00 133.00 104.00 107.00 97.00
Total Assets
372.00 297.00 295.00 279.00 226.00 194.00 181.00 137.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activity
-33.00 -8.00 -7.00 -6.00 4.00 13.00 13.00 4.00
Cash from Investing Activity
-3.00 -1.00 -6.00 -6.00 -8.00 -18.00 -37.00 -15.00
Cash from Financing Activity
64.00 -1.00 6.00 29.00 4.00 6.00 19.00 -4.00
Net Cash Flow
28.00 -11.00 -6.00 17.00 0.00 1.00 -5.00 -14.00
Free Cash Flow
-38.00 -10.00 -13.00 -13.00 -4.00 -5.00 -25.00 -11.00
CFO/OP %
-159.00 -47.00 -16.00 -13.00 30.00 88.00 88.00 48.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Debtor Days
151.00 155.00 112.00 169.00 200.00 170.00 145.00 129.00
Inventory Days
251.00 268.00 234.00 228.00 188.00 27.00 78.00 67.00
Days Payable
144.00 184.00 154.00 241.00 302.00 169.00 173.00 134.00
Cash Conversion Cycle
259.00 239.00 193.00 156.00 86.00 28.00 51.00 62.00
Working Capital Days
193.00 186.00 123.00 156.00 147.00 126.00 130.00 116.00
ROCE %
5.00 6.00 8.00 10.00 12.00 13.00 16.00 โ
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
40.46
40.46
40.46
40.46
40.46
43.16
42.99
42.99
42.99
43.21
43.21
43.21
FIIs
0.07
0.10
0.02
0.05
0.00
0.12
0.06
0.06
0.06
0.12
0.22
0.22
DIIs
0.40
0.00
0.44
0.59
0.64
0.69
0.87
1.17
1.17
0.99
0.67
0.20
Public
59.01
59.39
59.02
58.84
58.83
55.99
56.04
55.79
55.78
55.69
55.90
56.38
No. of Shareholders
11,047
10,806
10,967
11,177
10,808
10,435
10,576
10,792
10,652
10,639
10,252
9,419
Corporate Actions
10 records
Back to all stocks